As Derek Yach is gone, who is going to run the Foundation and what legitimacy/competence (if any) do they have. A closer look at the experience and background of each of the present members of the board of directors does not provide any reason to trust them to promote tobacco harm reduction. Indeed they were recruited by Derek (see our post about the evolution of the board and our post about the compensation and average time devoted by each board member to the Foundation work, according to the most recent, 2020, 990 form, scroll to page 56 of the pdf ) but he was really the only reason they came in. See below for yourself.
Pamela Parizek (Chair) Board member since March 22, 2018
$125,000 for 14 hpw but in 2019 she got $93,681 for the same 14 hpw.
Pamela J. Parizek is a managing director in the Business Intelligence and Investigations practice of Kroll, a division of Duff & Phelps, based in the Washington, D.C. office. She leads the Financial Investigations practice in North America. Pam is a recognized business leader, with more than 30 years of experience advising audit committees, C-suite executives and outside counsel on complex accounting, legal and regulatory matters.
Before joining Kroll, Pam served in the enforcement division of the SEC. She has also led the Washington, D.C. forensic practice of a Big Four accounting firm.
Over the past decade, Pam has led over 100 engagements in 30 countries, including numerous cross-border investigations into alleged anti-bribery and corruption violations. She has developed anti-bribery and corruption training programs, risk assessments, compliance audits, due diligence procedures and remediation plans for clients in EMEA, South America, APAC and the U.S. Her findings have been presented to the SEC, U.S. Department of Justice (DOJ), Serious Fraud Office, and other U.S. and foreign regulatory authorities—in compliance with restrictive data protection and privacy regimes around the world.
Pam has also conducted a wide variety of forensic accounting investigations involving overstatement of revenue, improper deferral of expenses, misappropriation of assets, manipulation of reserves, improper accounting for bonus accruals, performance rebates and accounts receivable reserves, premature recognition of software revenue, and improper capitalization of current period expenses. She specializes in crisis management involving multiple constituents, including but not limited to U.S. and foreign regulators, corporate boards and audit committees, C-suite executives, external counsel, independent auditors and other stakeholders.
Pam’s regulatory compliance engagements include acting as an independent auditor to a regulated entity to assess compliance with undertakings as per SEC and Commodity Futures Trading Commission (CFTC) orders. She was also appointed as an independent auditor in a False Claims Act matter to facilitate settlement among a global shipping company, the DOJ and the Department of Navy. She has acted as an external compliance advisor for several multilateral investment funds to administer annual financial disclosure programs. Earlier in her career, she served as a forensic accountant to the New York Stock Exchange (NYSE) regulatory auditor to assess whether the NYSE’s policies and procedures pertaining to its investigations and disciplinary program were reasonably designed to detect and deter violations of federal securities laws and NYSE rules governing floor members.
Pam holds a J.D. from Northwestern University School of Law and a B.A. from Harvard College. She is a licensed Certified Public Accountant in Virginia and the district of Columbia. She is also a member of the International Association of Independent Corporate Monitors.
Vandana Abramson, Board member since November 5, 2019
$45,245 for 1 hpw (used to be 2) (-1). that's $870 per hour
Associate Professor of Medicine, Vanderbilt University School of Medicine
Vandana Abramson is a medical oncologist at Vanderbilt University School of Medicine. She specializes in breast cancer, with a particular interest in the mechanisms of treatment response and resistance. Her research focuses on phase I/II clinical trials of novel combinations therapies, a topic on which she has published extensively. Dr. Abramson has been a principal investigator on over 30 clinical trials at Vanderbilt and is currently leading several national studies. She has received numerous accolades for her clinical work and research, including the Conquer Cancer Foundation’s Advanced Clinical Research Award in Breast Cancer.
Dr. Abramson received her undergraduate degree in English and Molecular & Cell Biology from the University of California, Berkeley, and her M.D. from the University of Chicago Pritzker School of Medicine. She subsequently completed a residency in Internal Medicine at Brigham and Women’s Hospital/Harvard Medical School, followed by a fellowship in medical oncology at the University of Pennsylvania, where she also obtained a master’s degree in Translational Research. Dr. Abramson is an active member of the American Society of Clinical Oncology.
Dyborn Chibonga, Board member since November 3, 2017
$50,000 for 1 hpw (used to be 8 hpw) (-7) that's $961 per hour
Dyborn Chibonga is the regional head for Malawi and Mozambique at the Alliance for a Green Revolution in Africa (AGRA), an alliance aimed to catalyze and sustain inclusive agriculture transformation for smallholder farmers in Africa.
He has more than 25 years of experience advocating for product diversification away from tobacco into other cash and food crops, as well as policy and regulatory reforms that promote food security and rural development.
Mr. Chibonga previously served as the CEO of the National Smallholder Farmers’ Association of Malawi (NASFAM) for 18 years. During this time, Mr. Chibonga grew the organization to more than 165,000 farmers, making it the largest smallholder-owned membership organization in Malawi. He transformed NASFAM from a small association into a sustainable business and a model for other countries to follow. Under Mr. Chibonga’s leadership, NASFAM established the Agricultural Commodity Exchange for Africa, a platform designed to encourage competitive bidding processes for smallholder farmers when selling their crops.
Mr. Chibonga is from Malawi and is a board member of the Cooperative Insurance Company of Malawi, the Jubilee University Council and the Commercial Agriculture Support Services. He holds a BS degree from the Bunda College of Agriculture at the University of Malawi and an MSc in landscape ecology design & maintenance from the University of London, where he also holds a master’s certificate in NGO management.
Paul Gardner, Board member since August 9, 2018
$50,000 for 5 hpw (used to be 7) (-2)
For over 35 years, Paul Gardner worked at a number of Australia’s leading agencies, the last 13 of which he served as Chairman of Grey Group Australia and New Zealand. He left to start his own business consulting practice (pgardner.com.au pty ltd), which specializes in branding and marketing communications as well as greenfield start-ups in Australia and overseas.
His current consultancy client base stretches across government, tourism, manufacturing, fashion, contract hire, and digital and consumer exhibitions. Outside of his own consultancy, Paul is currently an investor in a number of start-ups, operates his own podcast network (www.pgardner.com.au), and is a regular guest of The Politics HQ, broadcasting Friday evenings on Sky News.
A sensei (master) in Kyokushin karate, Paul is also actively involved in all aspects of Melbourne life through the arts, sports, education, and charity. In the 2008 Queen’s Birthday Honors list, he was appointed a Member of the Order of Australia (AM) for services to charity, the arts, and the advertising industry.
Corinna Lathan Board member since August 9, 2018
$50,000 for 7 hpw (used to be 11) (-4)
Dr. Corinna Lathan is CEO and founder of AnthroTronix, Inc., a biomedical engineering research and development company creating innovative products in digital health, wearable technology, robotics, and augmented reality.
Dr. Lathan has served as principal investigator on multiple grants from funding agencies such as DARPA, NASA, NIH, and NSF. Most recently, Dr. Lathan led the AnthroTronix team to develop DANA™, an FDA-cleared, mobile digital health software platform for the Department of Defense as a deployed diagnostic support to evaluate cognitive function during treatment for depression, brain injury, and post-traumatic stress. For this work, she was named a 2017 Woman to Watch by Disruptive Women in Health Care.
Dr. Lathan is founding co-chair of the World Economic Forum’s Global Future Council on Human Enhancement and is a thought leader on technology trends that impact health and health care. Dr. Lathan has been featured in Forbes, Time, and the New Yorker magazines, and her work has led to such distinctions as Maryland’s “Top Innovator of the Year,” MIT Technology Review magazine’s “Top 100 World Innovators,” and one of Fast Company magazine’s “Most Creative People in Business.” Dr. Lathan was named a Technology Pioneer and a Young Global Leader by the World Economic Forum and served as chair of their Global Agenda Council for Artificial Intelligence and Robotics.
Dr. Lathan serves as a director of PTC, Inc., a global technology provider of Internet of Things (IoT) and Augmented Reality platforms, and is a member of the audit committee. She also serves as a director of the non-profit boards Engineering World Health and the KID-Museum, and she is on the advisory board of the Smithsonian Institute’s Lemelson Center for the Study of Invention and Innovation.
Before founding AnthroTronix, Dr. Lathan was an associate professor of biomedical engineering at The Catholic University of America and an adjunct associate professor of Aerospace Engineering at the University of Maryland, College Park. Dr. Lathan received her BA in biopsychology and mathematics from Swarthmore College, and an MS in aeronautics and astronautics and PhD in neuroscience from MIT.
Angela Marshall Hoffmann, Board member since November 5, 2019
$45,245 for 1 hpw (stable). that's $870 per hour
Angela Marshall Hofmann is the Founder and President of World Strategies.
For over two decades, Angela has served as a trusted advisor to members of the U.S. Congress and Executive Branch as well as to CEOs and senior executives in complex, multi-national and non-profit organizations.
In 2015, Angela founded World Strategies, a woman-owned and operated consulting firm which focuses on supply chain and global investment advisory services including crisis management. She is also a staunch advocate for international trade and leads grassroots advocacy efforts on behalf of agricultural producers, manufacturers and small businesses.
Previously, she served as Vice President, International Corporate Affairs, at Walmart Stores, Inc. where she led the company’s external engagement in 40+ retail, ecommerce and sourcing countries around the world. In this capacity, she launched innovative public-private chain capacity building projects focused on transparency, building safety, agricultural development and women’s economic empowerment in Latin America, Asia and Africa. Angela joined the company in 2002 as Director of International Trade in the company’s Federal Government Relations office in Washington, D.C. and served nearly 14 years in roles including the International and Global Sourcing divisions.
Prior to Walmart, she served as agriculture and trade counsel to U.S. Senator Max Baucus and to the U.S. Senate Finance Committee under his chairmanship.
Noriko Tojo Board member since November 12, 2018
$ 50,000 for 2 hpw (used to be 6) (-4) that's $480 per hour
Noriko Tojo is Executive Director of Otsuka Holdings Co., Ltd., and President and Representative Director of Otsuka Medical Devices Co. Ltd.
Noriko joined Otsuka Holdings as Managing Director (Business Development) and Board Member in 2008 and added planning to her responsibilities in 2011. After 2012, she held various general management positions within Otsuka Group, including President and CEO of Otsuka America, Inc. and CEO of Pharmavite LLC before returning to Japan in 2017.
Noriko started her career at Goldman Sachs in Tokyo, Japan. After earning a graduate degree, she continued in investment banking at Lehman Brothers in New York City. She subsequently held positions at a startup marketing company in Tokyo, Japan, and a finance company in Bangkok, Thailand. She joined McKinsey & Company as a consultant in 1999 and became Engagement Manager in 2002. As a venture capital investor for Intel Capital in 2004, Noriko was responsible for Intel’s technology and business development–related equity investments in Japan.
In 2002, Noriko co-translated the second edition of “Valuation–Measuring and Managing the Value of Companies,” and she has written articles for professional magazines. She was also a panelist at the 2010 APEC Women’s Entrepreneurship Summit.
Noriko graduated from the University of Tokyo with a Bachelor of Laws degree and earned an MBA from Harvard University. She passed the Japanese National Bar Examination in 1999.
Comments